News of Note—Commercial production of Portola's Andexxa underway

> Lonza has begun commercial production in Spain of Portola’s second-generation Andexxa, a highly anticipated bleeding antidote for some anticoagulants. Release

> Indian biotech Enzene Biosciences has teamed up with Novasep for a purification installation for its plant in Pune, India, which will allow it to do end-to-end continuous manufacturing of a mAb. Release

> The FDA has gotten a federal court to prevent Ranier’s Compounding Laboratory in Jeanette, Pennsylvania, from making and selling compounded drugs on grounds that it has sold sterile injectables that failed to meet standards. Release